Inflammatory activity and anticardiolipin antibodies during tibolone treatment of healthy postmenopausal women

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 3, 2006, Pages 147-149

  Todorova, Maria ^a   Kamenov, Z ^a   Christov, V ^a   Baleva, M ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Anticardiolipin antibodies; C reactive protein (CRP); Menopause; Tibolone

Indexed keywords

C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TIBOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HEADACHE; HUMAN; INFLAMMATION; POSTMENOPAUSE; PROTEIN DETERMINATION; VAGINA BLEEDING;

ANTIBODIES, ANTICARDIOLIPIN; C-REACTIVE PROTEIN; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; INFLAMMATION; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; TIME FACTORS; UP-REGULATION;

EID: 33745310209     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.3.985168     Document Type: Article

References (10)

1. Winkler, U., Altkemper, R., Kwee, B., Helmond, F., Coelingh Bennink, H. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. Fertil Steril 2000, 74(1); 10-9.
2. Marchien van Baal, W., Emeis, J., van der Mooren, M., Kessel, H., Kenemans, P., Stehouwer, C. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomized, placebo-controlled 12-week study. Thromb Haemost 2000, 83: 29-34.
3. Todorova, M., Kamenov, Z., Baleva, M., Christov, V., Nicolov, K. Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women. Maturitas 2004, 48: 393-7.
4. Geusens, P., Dequeker, J., Gielen, J., Schot, L.P.C. Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis. Maturitas 1991, 13: 155-62
5. Ridker, P.M., Hennekens, C.H., Buring, J.E., Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342: 836-43.
6. Garnero, P., Jamin, C., Benhamou, C., Pelissier, C., Roux, C. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy postmenopausal women: A randomized trial. Hum Reprod 2002, 17: 2748-53.
7. Koh, K., Ahn, J.Y., Jin, D.K., et al. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: A randomized, double-blind, placebo-controlled, crossover study. Arterioscler Thromb Vasc Biol 2003, 23: 1889-94.
8. Szalai, A.J., van Ginkel, F., Dalrymple, S.A., Murray, R., McGhee, J.R., Volanakis, J.E. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 1998, 160: 5294-9.
9. Greaves, M. Antiphospholipid antibodies and thrombosis. Lancet 1999, 353: 1348-53.
10. Lahita, R. Hormonal contraception and replacement and the use of Androgens in the antiphospholipid syndrome. J Autoimmun 2000, 15: 213-6.